43. Cancer Res. 2018 Aug 1;78(15):4436-4442. doi: 10.1158/0008-5472.CAN-18-0187.Projections in Breast and Lung Cancer Mortality among Women: A Bayesian Analysis of 52 Countries Worldwide.Martín-Sánchez JC(1), Lunet N(2)(3), González-Marrón A(1), Lidón-Moyano C(1),Matilla-Santander N(1), Clèries R(4)(5), Malvezzi M(6), Negri E(7), Morais S(2), Costa AR(2), Ferro A(2), Lopes-Conceição L(2), La Vecchia C(6), Martínez-Sánchez JM(8)(9).Author information: (1)Grupo de Evaluación de Determinantes de Salud y Políticas Sanitarias,Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.(2)EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nPorto, Portugal.(3)Departamento de Ciências da Saúde Pública e Forenses e Educação Médica,Faculdade de Medicina da Universidade do Porto, Al. Prof. Hernâni Monteiro,Porto, Portugal.(4)Pla Director d'Oncologia (GENCAT), IDIBELL, Hospital Duran i Reynals,L'Hospitalet de Llobregat, Barcelona, Spain.(5)Departament de Ciències Clíniques, Universitat de Barcelona, Campus deBellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.(6)Department of Clinical Sciences and Community Health, Università degli Studidi Milano, Milan, Italy.(7)Department of Biomedical and Clinical Sciences, Università degli Studi diMilano, Milan, Italy.(8)Grupo de Evaluación de Determinantes de Salud y Políticas Sanitarias,Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.jmmartinez@uic.es.(9)Unidad de Control del Tabaco, Programa de Prevención y Control del Cáncer,Instituto Catalán de Oncología (ICO), L'Hospitalet de Llobregat, Spain.Among women, lung cancer mortality rates have surpassed those for breast cancerin several countries. This reflects the breast cancer mortality declines due toaccess to screening and effective treatment alongside the entrance of certaincountries in stages of the tobacco epidemic in which smoking becomes moreprevalent in women. In this study, we project lung and breast cancer mortalityuntil 2030 in 52 countries. Cancer mortality data were obtained from the WHOMortality Database. Age-standardized mortality rates (ASMR), per 100,000, werecalculated (direct method) for 2008 to 2014 and projected for the years 2015,2020, 2025, and 2030 using a Bayesian log-linear Poisson model. In 52 countriesstudied around the world, between 2015 and 2030, the median ASMR are projected toincrease for lung cancer, from 11.2 to 16.0, whereas declines are expected forbreast cancer, from 16.1 to 14.7. In the same period, the ASMR will decrease in36 countries for breast cancer and in 15 countries for lung cancer. In half ofthe countries analyzed, and in nearly three quarters of those classified ashigh-income countries, the ASMR for lung cancer has already surpassed or willsurpass the breast cancer ASMR before 2030. The mortality for lung and breastcancer is higher in high-income countries than in middle-income countries; lungcancer mortality is lower in the latter because the tobacco epidemic is not yetwidespread. Due to these observed characteristics of lung cancer, primaryprevention should still be a key factor to decrease lung cancermortality.Significance: The mortality for lung and breast cancer is projected to be higher in high-income countries than in middle-income countries, where lungcancer mortality is expected to surpass breast cancer mortality before 2030.Cancer Res; 78(15); 4436-42. ©2018 AACR.©2018 American Association for Cancer Research.DOI: 10.1158/0008-5472.CAN-18-0187 PMID: 30068667 